Bipolar Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Bipolar Disorder stocks.

Bipolar Disorder Stocks Recent News

Date Stock Title
May 6 LLY Investors Pile Into Amgen in Search of Next Obesity Drug Payout
May 6 AZN The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes
May 6 LLY 2 Top Stocks That Could Make You Richer in 2024
May 6 AZN Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
May 5 LLY 3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
May 5 LLY 3 No-Brainer Stocks to Buy in May
May 4 LLY Pharma R&D productivity seen improving for the first time in years - Deloitte
May 4 LLY Eli Lilly: Great Time To Divest Before It Potentially Crashes
May 4 LLY Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
May 4 LLY Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
May 4 LLY Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
May 3 LLY Amazon Stock Is on a Roll. Here’s Why It’s on This Firm’s ‘Best Ideas List.’
May 3 LLY Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
May 3 LLY Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
May 3 LLY Analyst unveils Amgen stock price target after weight-loss drug data
May 3 AZN Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx
May 3 LLY Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
May 3 AZN Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
May 3 LLY Weight-loss drug competition heats up. Is Wegovy in trouble?
May 3 LLY Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Bipolar Disorder

Bipolar disorder, previously known as manic depression, is a mental disorder that causes periods of depression and periods of abnormally elevated mood. The elevated mood is significant and is known as mania or hypomania, depending on its severity, or whether symptoms of psychosis are present. During mania, an individual behaves or feels abnormally energetic, happy, or irritable. Individuals often make poorly thought out decisions with little regard to the consequences. The need for sleep is usually reduced during manic phases. During periods of depression, there may be crying, a negative outlook on life, and poor eye contact with others. The risk of suicide among those with the illness is high at greater than 6 percent over 20 years, while self-harm occurs in 30–40 percent. Other mental health issues such as anxiety disorders and substance use disorder are commonly associated with bipolar disorder.The causes are not clearly understood, but both environmental and genetic factors play a role. Many genes of small effect contribute to risk. Environmental risk factors include a history of childhood abuse and long-term stress. About 85% of the risk is attributed to genetics. The condition is classified as bipolar I disorder if there has been at least one manic episode, with or without depressive episodes, and as bipolar II disorder if there has been at least one hypomanic episode (but no manic episodes) and one major depressive episode. In those with less severe symptoms of a prolonged duration, the condition cyclothymic disorder may be diagnosed. If the symptoms are due to drugs or medical problems, it is classified separately. Other conditions that may present similarly include attention deficit hyperactivity disorder, personality disorders, schizophrenia and substance use disorder as well as a number of medical conditions. Medical testing is not required for a diagnosis, though blood tests or medical imaging can be done to rule out other problems.Treatment commonly includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. Examples of mood stabilizers that are commonly used include lithium and various anticonvulsants. Involuntary treatment in a hospital may be needed if a person is a risk to themselves or others but refuses treatment. Severe behavioral problems, such as agitation or combativeness, may be managed with short term antipsychotics or benzodiazepines. In periods of mania, it is recommended that antidepressants be stopped. If antidepressants are used for periods of depression, they should be used with a mood stabilizer. Electroconvulsive therapy (ECT), while not very well studied, may be tried for those who do not respond to other treatments. If treatments are stopped, it is recommended that this be done slowly. Many individuals have financial, social or work-related problems due to the illness. These difficulties occur a quarter to a third of the time, on average. Due to poor lifestyle choices and side effects from medications, the risk of death from natural causes such as heart disease is twice that of the general population.Bipolar disorder affects approximately 1% of the global population. In the United States, about 3% are estimated to be affected at some point in their life; rates appear to be similar in females and males. The most common age at which symptoms begin is 25. The economic cost of the disorder has been estimated at $45 billion for the United States in 1991. A large proportion of this was related to a higher number of missed work days, estimated at 50 per year. People with bipolar disorder often face problems with social stigma.

Browse All Tags